Brief: Complaint Filed Against Organon Board, Sun Pharma USA, Sun Pharma America- SEC Filing
BRIEF-Complaint Filed Against Organon Board, Sun Pharma USA, Sun Pharma America- SEC Filing July 17 (Reuters) - Organon & Co OGN.N:
ORGANON & CO - COMPLAINT FILED JULY 6, 2026 AGAINST ORGANON BOARD, SUN PHARMA USA, SUN PHARMA AMERICA- SEC FILING
ORGANON & CO: BELIEVES THAT CLAIMS, ALLEGATIONS IN COMPLAINT & ASSERTIONS IN PENDING INJUNCTION MOTION ARE WITHOUT MERIT
Source text: [ID:n0001193125-26-307767]
Further company coverage: OGN.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Organon & Co.
See all newsIndia's Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say
Brief: Organon & Co Says It Does Not Expect To Record Milestone Expense In Q3 2026
India's Persistent Systems plans debut rupee debt sale to fund acquisition, bankers say
India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
Organon & Co reports results for the quarter ended June 30 - Earnings Summary